Immunoglobulin Therapy and Primary Immunodeficient Patients' Health-Related Quality of Life and Well-Being

Immunoglobulin Therapy and Primary Immunodeficient Patients' Health-Related Quality of Life and Well-Being

Individuals born with primary immune deficiency diseases (PIDD) have a dysfunctional immune system, and many are treated by lifelong injections of immunoglobulin therapy. Studies have shown that these patients have low health-related quality of life (HRQOL) and well-being (WB) and that these outcome...

Full description

Bibliographic Details
Main Author: Heckman, Niedre
Format: Others
Language:en
Published: ScholarWorks 2018
Subjects:
Biopsychosocial model
HRQoL and Well-being
Immunoglobulin replacement therapy
Patient-reported outcomes
Primary Immunodeficiecy Diseases
Rare chronic diseases
Allergy and Immunology
Immunology and Infectious Disease
Medical Immunology
Pharmacy and Pharmaceutical Sciences
Public Health Education and Promotion
Online Access:https://scholarworks.waldenu.edu/dissertations/4789
https://scholarworks.waldenu.edu/cgi/viewcontent.cgi?article=6068&context=dissertations

Internet

https://scholarworks.waldenu.edu/dissertations/4789
https://scholarworks.waldenu.edu/cgi/viewcontent.cgi?article=6068&context=dissertations

Similar Items